
Veterinary Drug Market by Drug Type (Anti-Infective, Anti-Inflammatory, Parasiticide), Animal Type (Companion Animal, Livestock Animal), Route of Administration - Global Forecast 2024-2030
Description
Veterinary Drug Market by Drug Type (Anti-Infective, Anti-Inflammatory, Parasiticide), Animal Type (Companion Animal, Livestock Animal), Route of Administration - Global Forecast 2024-2030
The Veterinary Drug Market size was estimated at USD 23.03 billion in 2023 and expected to reach USD 24.39 billion in 2024, at a CAGR 5.98% to reach USD 34.60 billion by 2030.
Global Veterinary Drug Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Drug Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Drug Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Veterinary Drug Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Veterinary Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:
Drug Type
Anti-Infective
Anti-Inflammatory
Parasiticide
Animal Type
Companion Animal
Livestock Animal
Route of Administration
Oral
Parenteral
Topical
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Veterinary Drug Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Drug Market?
3. What are the technology trends and regulatory frameworks in the Veterinary Drug Market?
4. What is the market share of the leading vendors in the Veterinary Drug Market?
5. Which modes and strategic moves are suitable for entering the Veterinary Drug Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
192 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Veterinary Drug Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing pet ownership and livestock population in economies
- 5.1.1.2. Growing penetration of pet insurance
- 5.1.1.3. Growing availability of numerous veterinary drugs for treatment of several diseases
- 5.1.2. Restraints
- 5.1.2.1. High pet care cost
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of new and advanced veterinary drugs
- 5.1.3.2. Expansion of animal healthcare expenditure
- 5.1.4. Challenges
- 5.1.4.1. Complexities associated with the production
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Veterinary Drug Market, by Drug Type
- 6.1. Introduction
- 6.2. Anti-Infective
- 6.3. Anti-Inflammatory
- 6.4. Parasiticide
- 7. Veterinary Drug Market, by Animal Type
- 7.1. Introduction
- 7.2. Companion Animal
- 7.3. Livestock Animal
- 8. Veterinary Drug Market, by Route of Administration
- 8.1. Introduction
- 8.2. Oral
- 8.3. Parenteral
- 8.4. Topical
- 9. Americas Veterinary Drug Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Veterinary Drug Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Veterinary Drug Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Biogenesis Bago SA
- 13.1.2. Boehringer Ingelheim International GmbH
- 13.1.3. Ceva Sante Animale
- 13.1.4. Dechra Pharmaceuticals PLC
- 13.1.5. Elanco Animal Health Incorporated
- 13.1.6. Evonik Industries AG
- 13.1.7. Hester Biosciences Limited
- 13.1.8. Huvepharma, Inc.
- 13.1.9. Merck & Co., Inc.
- 13.1.10. Neogen Corporation
- 13.1.11. Nutreco N.V.
- 13.1.12. Perrigo Company PLC
- 13.1.13. Vetoquinol S.A.
- 13.1.14. Virbac S.A.
- 13.1.15. Zoetis Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. VETERINARY DRUG MARKET RESEARCH PROCESS
- FIGURE 2. VETERINARY DRUG MARKET SIZE, 2023 VS 2030
- FIGURE 3. VETERINARY DRUG MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. VETERINARY DRUG MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. VETERINARY DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. VETERINARY DRUG MARKET DYNAMICS
- FIGURE 7. VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 8. VETERINARY DRUG MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
- FIGURE 10. VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 12. VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES VETERINARY DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.